Journal article
Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D
- Abstract:
-
Plasmablastic B-cell malignancies include plasmablastic lymphoma and subsets of multiple myeloma and diffuse large B-cell lymphoma (DLBCL). These diseases can be difficult to diagnose and treat, and lack well-characterised cell line models. Here, immunophenotyping and FOXP1 expression profiling identified plasmablastic characteristics in DLBCL cell lines HLY-1 and SU-DHL-9, associated with CTNNAL1, HPGD, RORα, IGF1 and/or vitamin D receptor (VDR) transcription. We demonstrated VDR protein exp...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
+ National
Institute for Health Research Oxford Biomedical Research Centre
More from this funder
Funding agency for:
Banham, A
Grant:
10044, 13047
Bibliographic Details
- Publisher:
- Endocrine Society Publisher's website
- Journal:
- Endocrinology Journal website
- Volume:
- 158
- Issue:
- 3
- Pages:
- 503-515
- Publication date:
- 2016-12-21
- Acceptance date:
- 2016-12-19
- DOI:
- EISSN:
-
1945-7170
- ISSN:
-
0013-7227
- Source identifiers:
-
667531
Item Description
- Language:
- English
- Pubs id:
-
pubs:667531
- UUID:
-
uuid:dc0683d6-030b-483e-8684-31e615b8cc36
- Local pid:
- pubs:667531
- Deposit date:
- 2017-01-06
Terms of use
- Copyright holder:
- Endocrine Society
- Copyright date:
- 2016
- Notes:
-
Copyright © 2017 by the Endocrine Society.
This article is published under the terms of the Creative Commons Attribution-Non
Commercial License (CC-BY-NC; https://creativecommons.org/licenses/by-nc/4.0/).
If you are the owner of this record, you can report an update to it here: Report update to this record